Aurinia Pharmaceuticals Ownership | Who Owns Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals Ownership Summary
Aurinia Pharmaceuticals is owned by 40.24% institutional investors, 7.22% insiders, and 52.54% retail investors. Blackrock is the largest institutional shareholder, holding 6.44% of AUPH shares. iShares Russell 2000 ETF is the top mutual fund, with 2.56% of its assets in Aurinia Pharmaceuticals shares.
AUPH Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Aurinia Pharmaceuticals | 40.24% | 7.22% | 52.54% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 9.27M | 6.44% | $52.94M |
| Blackrock funding, inc. /de | 8.95M | 6.26% | $80.39M |
| Tang capital management | 8.43M | 5.89% | $75.70M |
| Armistice capital | 6.40M | 4.47% | $57.47M |
| Nea management company | 3.97M | 2.78% | $35.65M |
| State street | 2.92M | 2.04% | $26.20M |
| Geode capital management | 1.76M | 1.23% | $15.84M |
| Goldman sachs group | 1.75M | 1.22% | $15.73M |
| Vanguard group | 1.73M | 1.21% | $15.53M |
| Nuveen asset management | 1.49M | 1.04% | $13.40M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tang capital management | 8.43M | 5.01% | $75.70M |
| Nea management company | 3.97M | 2.01% | $35.65M |
| Armistice capital | 6.40M | 0.78% | $57.47M |
| Virtus investment advisers | 82.83K | 0.58% | $743.79K |
| Ironwood investment management | 94.31K | 0.42% | $846.90K |
| Pdt partners | 301.55K | 0.24% | $2.71M |
| Virtus fund advisers | 7.03K | 0.20% | $63.15K |
| Virtus etf advisers | 36.08K | 0.13% | $324.03K |
| Highmark wealth management | 21.70K | 0.11% | $194.83K |
| Sunbelt securities | 160.22K | 0.09% | $914.88K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tang capital management | 8.43M | 5.01% | 1.20M |
| Arrowstreet capital, limited partnership | 1.08M | 0.01% | 1.08M |
| Point72 asset management | 849.62K | 0.02% | 849.62K |
| Blackrock | 9.27M | 0.00% | 609.18K |
| Lazard asset management | 596.39K | 0.01% | 461.43K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | 6.40M | 0.78% | -1.80M |
| Rock springs capital management lp | - | - | -1.18M |
| Schroder investment management group | - | - | -997.22K |
| Goldman sachs group | 1.75M | 0.00% | -655.85K |
| 683 capital management | - | - | -400.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Arrowstreet capital, limited partnership | 1.08M | 0.01% | 1.08M | $9.66M |
| Point72 asset management | 849.62K | 0.02% | 849.62K | $7.63M |
| Qube research | 195.76K | 0.00% | 195.76K | $1.76M |
| Squarepoint ops | 116.60K | 0.00% | 116.60K | $1.05M |
| Norges bank | 114.05K | 0.00% | 114.05K | $651.20K |
Sold Out
| Holder | Change |
|---|---|
| Vima | -25.00 |
| Nelson, van denburg & campbell wealth management group | -26.00 |
| Walleye trading | -300.00 |
| Spectrum wealth counsel | -334.00 |
| Lowe wealth advisors | -531.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 210 | 6.60% | 57,561,302 | -0.09% | 40 | 2.48% | 98 | 16.67% | 49 | 11.36% |
| Sep 30, 2024 | 195 | 7.73% | 57,393,945 | 3.76% | 40 | 2.69% | 83 | -2.35% | 43 | - |
| Jun 30, 2024 | 180 | -8.63% | 55,314,751 | 0.64% | 38 | 2.61% | 85 | 13.33% | 42 | -32.26% |
| Mar 31, 2024 | 197 | -6.19% | 54,961,177 | 3.27% | 38 | 2.78% | 75 | -9.64% | 62 | 1.64% |
| Dec 31, 2023 | 210 | -2.78% | 53,221,003 | 5.95% | 37 | 3.00% | 83 | -10.75% | 61 | 22.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Russell 2000 ETF | 3.52M | 2.56% | -30.47K |
| Fidelity Small Cap Index | 1.33M | 0.97% | -24.83K |
| International Biotechnology Ord | 997.22K | 0.70% | - |
| Nuveen Quant Small Cap Equity R6 | 870.24K | 0.63% | -226.90K |
| iShares Russell 2000 Growth ETF | 868.68K | 0.63% | -4.13K |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 827.90K | 0.60% | - |
| State St Russell Sm/Mid Cp® Indx SL Cl I | 820.80K | 0.60% | -7.10K |
| iShares Biotechnology ETF | 789.07K | 0.57% | -8.79K |
| Vanguard Russell 2000 ETF | 615.11K | 0.45% | 18.15K |
| State St Russell Sm Cap® Indx SL Cl I | 464.95K | 0.34% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 07, 2025 | Keenan Greg | Chief Medical Officer | Sell | $68.35K |
| Mar 04, 2025 | Greenleaf Peter | Chief Executive Officer | Sell | $1.31M |
| Mar 03, 2025 | Greenleaf Peter | Chief Executive Officer | Sell | $1.56M |
| Mar 03, 2025 | Keenan Greg | Chief Medical Officer | Sell | $97.91K |
| Mar 03, 2025 | Miller Joseph M | Chief Financial Officer | Sell | $494.87K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | 6 | 10 |
| 2024 Q4 | 3 | 2 |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | 5 |
| 2024 Q1 | - | 8 |
AUPH Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools